Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography
Tiedosto(t)
Rinnakkaistallenteen versio
published versionPäivämäärä
2018Tekijä(t)
Yksilöllinen tunniste
10.1038/s41598-018-27618-4Metadata
Näytä kaikki kuvailutiedotLisätietoa
Rinnakkaistallenne
Viittaus
Silvola, JMU. Li, XG. Virta, J. Marjamäki, P. Liljenbäck, H. Hytönen, JP. Tarkia, M. Saunavaara, V. Hurme, S. Palani, S. Hakovirta, H. Ylä-Herttuala, S. Saukko, P. Chen, Q. Low, PS. Knuuti, J. Saraste, A. Roivainen, A. (2018). Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography. Scientific Reports, 8 (1) , 9720. 10.1038/s41598-018-27618-4.Oikeudet
Tiivistelmä
Inflammation plays an important role in the development of atherosclerosis and its complications. Because the folate receptor β (FR-β) is selectively expressed on macrophages, an FR targeted imaging agent could be useful for assessment of atherosclerotic inflammation. We investigated aluminum fluoride-18-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid conjugated folate (18F-FOL) for the detection of atherosclerotic plaque inflammation. We studied atherosclerotic plaques in mice, rabbits, and human tissue samples using 18F-FOL positron emission tomography/computed tomography (PET/CT). Compound 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) was used as a comparison. Firstly, we found that the in vitro binding of 18F-FOL co-localized with FR-β-positive macrophages in carotid endarterectomy samples from patients with recent ischemic symptoms. We then demonstrated specific accumulation of intravenously administered 18F-FOL in atherosclerotic plaques in mice and rabbits using PET/CT. We noticed that the 18F-FOL uptake correlated with the density of macrophages in plaques and provided a target-to-background ratio as high as 18F-FDG, but with considerably lower myocardial uptake. Thus, 18F-FOL PET/CT targeting of FR-β-positive macrophages presents a promising new tool for the in vivo imaging of atherosclerotic inflammation.
Linkki alkuperäiseen julkaisuun
http://dx.doi.org/10.1038/s41598-018-27618-4Julkaisija
Springer NatureKokoelmat
- Terveystieteiden tiedekunta [1735]